OliX Pharmaceuticals to Present at Global RNAi-Based Therapeutics Summit

He will also present the advantages of Cell-Penetrating Asymmetric Interfering RNA (cp-asiRNA), OliX Pharmaceuticals proprietary RNAi delivery method that efficiently silences gene expressions which can be locally administered to target various diseases with unmet needs.